Muscular Diseases

Our cTA™ platform delivers robust solutions to evaluate the broader context of muscle fibers to help determine therapeutic impact and potential biomarker expression.

Our Solutions

Learn more about how our cTA™ platform can precisely report novel endpoints while interpreting context of the surrounding tissue.

  • We leverage proprietary algorithms specifically designed and validated to assess biomarker expression in muscle tissue samples.
  • Our quantifiable, reproducible data and experienced consultative team provides understanding of high complex staining, enabling critical decisions to be made with confidence.
 

Duplex immunohistochemical (IHC) assay with staining for utrophin and laminin α2 biomarkers

Duplex IHC-cTA™ based assay with markup showing representative biomarker intensity by individual cell.

Whole slide analysis of muscle sections

Multi-analyte analysis of morphological features of individual muscle fibers

Industry Resources

Find out more about patient advocacy groups in muscular diseases and how to be involved.

Patient Advocacy Groups

SOLVE DIFFICULT TISSUE ANALYSIS CHALLENGES WITH OUR UNIQUE APPROACH

Work With Us

Breadth and depth in people and technology to deliver on any challenge
Work With Us